12:00 AM
 | 
May 01, 2000
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Intercept Platelet System: Phase III study

The product is partnered with Baxter Healthcare Corp. (BAX, Deerfield, Ill.).

Cerus Corp. (CERS), Concord, Calif.
Product: Intercept Platelet System
Business: Blood products/substitutes...

Read the full 110 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >